한글목차

세계 폐암 치료 시장 규모는 2024-2029년 123억 7,000만 달러 증가하고, 예측 기간 동안 8.3%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

세계의 폐암 치료 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.

이 보고서는 현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 면역 조절제의 큰 기여, 폐암의 높은 유병률, 환자 지원 프로그램 증가에 의해 주도되고 있습니다.

본 조사는 업계 주요 참여자의 의견을 포함하여 1차 정보와 2차 정보를 객관적으로 조합하여 실시되었습니다. 이 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역별 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 실적 데이터와 예측 데이터가 있습니다.

이 보고서는 향후 몇 년동안 폐암 치료 시장의 성장을 가속하는 주요 이유 중 하나로 재생 치료의 출현을 꼽았습니다. 또한, 전략적 제휴 증가와 단백질 바이오마커의 출현은 시장의 큰 수요로 이어질 것입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 Technavio 분석

• 가격 민감도, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
• 인풋의 중요성과 차별화 요인
• 파괴적 변화 요인
• 성장 촉진요인과 과제의 영향

제3장 시장 구도

• 시장 생태계
• 시장 특징
• 밸류체인 분석

제4장 시장 규모

• 시장의 정의
• 시장 부문 분석
• 시장 규모(2024년)
• 시장 전망(2024-2029년)

제5장 시장 규모 실적

• 세계의 폐암 치료 시장(2019-2023년)
• 요법별 부문 분석(2019-2023년)
• 유형별 부문 분석(2019-2023년)
• 최종사용자별 부문 분석(2019-2023년)
• 지역별 부문 분석(2019-2023년)
• 국가별 부문 분석(2019-2023년)

제6장 정성 분석

• AI의 영향 : 세계의 폐암 치료 시장

제7장 Five Forces 분석

• Five Forces 요약
• 바이어의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁 위협
• 시장 현황

제8장 시장 세분화 : 요법별

• 시장 부문
• 비교 : 요법별
• 표적치료 : 시장 규모와 예측(2024-2029년)
• 면역치료 : 시장 규모와 예측(2024-2029년)
• 화학요법 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 요법별

제9장 시장 세분화 : 유형별

• 시장 부문
• 비교 : 유형별
• NSCLC : 시장 규모와 예측(2024-2029년)
• SCLC : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 유형별

제10장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 병원 및 전문의 : 시장 규모와 예측(2024-2029년)
• 연구기관 및 학술센터 : 시장 규모와 예측(2024-2029년)
• 기타 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 최종사용자별

제11장 고객 상황

• 고객 상황 개요

제12장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측(2024-2029년)
• 유럽 : 시장 규모와 예측(2024-2029년)
• 아시아 : 시장 규모와 예측(2024-2029년)
• 세계 기타 지역 : 시장 규모와 예측(2024-2029년)
• 미국 : 시장 규모와 예측(2024-2029년)
• 영국 : 시장 규모와 예측(2024-2029년)
• 캐나다 : 시장 규모와 예측(2024-2029년)
• 중국 : 시장 규모와 예측(2024-2029년)
• 일본 : 시장 규모와 예측(2024-2029년)
• 프랑스 : 시장 규모와 예측(2024-2029년)
• 독일 : 시장 규모와 예측(2024-2029년)
• 인도 : 시장 규모와 예측(2024-2029년)
• 스페인 : 시장 규모와 예측(2024-2029년)
• 한국 : 시장 규모와 예측(2024-2029년)
• 시장 기회 : 지역 상황별

제13장 성장 촉진요인, 과제, 기회 및 성장 억제요인

• 시장 성장 촉진요인
• 시장이 해결해야 할 과제
• 성장 촉진요인과 과제의 영향
• 시장 기회와 성장 억제요인

제14장 경쟁 구도

• 개요
• 경쟁 구도
• 파괴적 변화 상황
• 업계 리스크

제15장 경쟁 분석

• 기업 개요
• 기업 순위 지수
• 기업의 시장 포지셔닝
• AbbVie Inc.
• Amgen Inc.
• Astellas Pharma Inc.
• AstraZeneca Plc
• Boehringer Ingelheim International GmbH
• Bristol Myers Squibb Co.
• Daiichi Sankyo Co. Ltd.
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Merck and Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.

제16장 부록

영문목차

The lung cancer therapeutics market is forecasted to grow by USD 12.37 billion during 2024-2029, accelerating at a CAGR of 8.3% during the forecast period. The report on the lung cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by heavy contribution of immunomodulators, strong prevalence of lung cancer, and increasing number of patient assistance programs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's lung cancer therapeutics market is segmented as below:

By Therapy

• Targeted therapy
• Immunotherapy
• Chemotherapy

By Type

• NSCLC
• SCLC

By End-user

• Hospitals and specialist clinics
• Research institutions and academic centers
• Other

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advent of regenerative therapies as one of the prime reasons driving the lung cancer therapeutics market growth during the next few years. Also, increasing strategic alliances and advent of protein biomarkers will lead to sizable demand in the market.

The report on the lung cancer therapeutics market covers the following areas:

• Lung Cancer Therapeutics Market sizing
• Lung Cancer Therapeutics Market forecast
• Lung Cancer Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading lung cancer therapeutics market vendors that include AbbVie Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Galecto Inc., GlaxoSmithKline PLC, IOVANCE Biotherapeutics Inc., Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novartis AG, Parexel International Corp., Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd.. Also, the lung cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Therapy
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Global - Market size and forecast 2024-2029 ($ billion)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Lung Cancer Therapeutics Market 2019 - 2023
  • Historic Market Size - Data Table on Global Lung Cancer Therapeutics Market 2019 - 2023 ($ billion)
• 5.2 Therapy segment analysis 2019 - 2023
  • Historic Market Size - Therapy Segment 2019 - 2023 ($ billion)
• 5.3 Type segment analysis 2019 - 2023
  • Historic Market Size - Type Segment 2019 - 2023 ($ billion)
• 5.4 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

• 6.1 AI Impact on Global Lung Cancer Therapeutics Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Therapy

• 8.1 Market segments
  • Chart on Therapy - Market share 2024-2029 (%)
  • Data Table on Therapy - Market share 2024-2029 (%)
• 8.2 Comparison by Therapy
  • Chart on Comparison by Therapy
  • Data Table on Comparison by Therapy
• 8.3 Targeted therapy - Market size and forecast 2024-2029
  • Chart on Targeted therapy - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Targeted therapy - Market size and forecast 2024-2029 ($ billion)
  • Chart on Targeted therapy - Year-over-year growth 2024-2029 (%)
  • Data Table on Targeted therapy - Year-over-year growth 2024-2029 (%)
• 8.4 Immunotherapy - Market size and forecast 2024-2029
  • Chart on Immunotherapy - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Immunotherapy - Market size and forecast 2024-2029 ($ billion)
  • Chart on Immunotherapy - Year-over-year growth 2024-2029 (%)
  • Data Table on Immunotherapy - Year-over-year growth 2024-2029 (%)
• 8.5 Chemotherapy - Market size and forecast 2024-2029
  • Chart on Chemotherapy - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Chemotherapy - Market size and forecast 2024-2029 ($ billion)
  • Chart on Chemotherapy - Year-over-year growth 2024-2029 (%)
  • Data Table on Chemotherapy - Year-over-year growth 2024-2029 (%)
• 8.6 Market opportunity by Therapy
  • Market opportunity by Therapy ($ billion)
  • Data Table on Market opportunity by Therapy ($ billion)

9 Market Segmentation by Type

• 9.1 Market segments
  • Chart on Type - Market share 2024-2029 (%)
  • Data Table on Type - Market share 2024-2029 (%)
• 9.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 9.3 NSCLC - Market size and forecast 2024-2029
  • Chart on NSCLC - Market size and forecast 2024-2029 ($ billion)
  • Data Table on NSCLC - Market size and forecast 2024-2029 ($ billion)
  • Chart on NSCLC - Year-over-year growth 2024-2029 (%)
  • Data Table on NSCLC - Year-over-year growth 2024-2029 (%)
• 9.4 SCLC - Market size and forecast 2024-2029
  • Chart on SCLC - Market size and forecast 2024-2029 ($ billion)
  • Data Table on SCLC - Market size and forecast 2024-2029 ($ billion)
  • Chart on SCLC - Year-over-year growth 2024-2029 (%)
  • Data Table on SCLC - Year-over-year growth 2024-2029 (%)
• 9.5 Market opportunity by Type
  • Market opportunity by Type ($ billion)
  • Data Table on Market opportunity by Type ($ billion)

10 Market Segmentation by End-user

• 10.1 Market segments
  • Chart on End-user - Market share 2024-2029 (%)
  • Data Table on End-user - Market share 2024-2029 (%)
• 10.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 10.3 Hospitals and specialist clinics - Market size and forecast 2024-2029
  • Chart on Hospitals and specialist clinics - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Hospitals and specialist clinics - Market size and forecast 2024-2029 ($ billion)
  • Chart on Hospitals and specialist clinics - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospitals and specialist clinics - Year-over-year growth 2024-2029 (%)
• 10.4 Research institutions and academic centers - Market size and forecast 2024-2029
  • Chart on Research institutions and academic centers - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Research institutions and academic centers - Market size and forecast 2024-2029 ($ billion)
  • Chart on Research institutions and academic centers - Year-over-year growth 2024-2029 (%)
  • Data Table on Research institutions and academic centers - Year-over-year growth 2024-2029 (%)
• 10.5 Other - Market size and forecast 2024-2029
  • Chart on Other - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Other - Market size and forecast 2024-2029 ($ billion)
  • Chart on Other - Year-over-year growth 2024-2029 (%)
  • Data Table on Other - Year-over-year growth 2024-2029 (%)
• 10.6 Market opportunity by End-user
  • Market opportunity by End-user ($ billion)
  • Data Table on Market opportunity by End-user ($ billion)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ billion)
  • Data Table on North America - Market size and forecast 2024-2029 ($ billion)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 12.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 12.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 12.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ billion)
  • Data Table on US - Market size and forecast 2024-2029 ($ billion)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 12.8 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ billion)
  • Data Table on UK - Market size and forecast 2024-2029 ($ billion)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 12.9 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 12.10 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ billion)
  • Data Table on China - Market size and forecast 2024-2029 ($ billion)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 12.11 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 12.12 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ billion)
  • Data Table on France - Market size and forecast 2024-2029 ($ billion)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 12.13 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 12.14 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ billion)
  • Data Table on India - Market size and forecast 2024-2029 ($ billion)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 12.15 Spain - Market size and forecast 2024-2029
  • Chart on Spain - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
  • Chart on Spain - Year-over-year growth 2024-2029 (%)
  • Data Table on Spain - Year-over-year growth 2024-2029 (%)
• 12.16 South Korea - Market size and forecast 2024-2029
  • Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
  • Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
  • Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
• 12.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ billion)
  • Data Tables on Market opportunity By Geographical Landscape ($ billion)

13 Drivers, Challenges, and Opportunity/Restraints

• 13.1 Market drivers
• 13.2 Market challenges
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities/restraints

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Product / Service
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • SWOT
• 15.5 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key news
  • Amgen Inc. - Key offerings
  • SWOT
• 15.6 Astellas Pharma Inc.
  • Astellas Pharma Inc. - Overview
  • Astellas Pharma Inc. - Product / Service
  • Astellas Pharma Inc. - Key offerings
  • SWOT
• 15.7 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
  • SWOT
• 15.8 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
  • SWOT
• 15.9 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
  • SWOT
• 15.10 Daiichi Sankyo Co. Ltd.
  • Daiichi Sankyo Co. Ltd. - Overview
  • Daiichi Sankyo Co. Ltd. - Product / Service
  • Daiichi Sankyo Co. Ltd. - Key offerings
  • SWOT
• 15.11 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key offerings
  • SWOT
• 15.12 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.13 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
  • SWOT
• 15.14 Merck and Co. Inc.
  • Merck and Co. Inc. - Overview
  • Merck and Co. Inc. - Business segments
  • Merck and Co. Inc. - Key news
  • Merck and Co. Inc. - Key offerings
  • Merck and Co. Inc. - Segment focus
  • SWOT
• 15.15 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
  • SWOT
• 15.16 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
• 15.17 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
• 15.18 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations